Role of the interferon regulatory factor 5 in the development of lupus nephritis
Project/Area Number |
22590893
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Kidney internal medicine
|
Research Institution | Saga University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
KOARADA Syuichi 佐賀大学, 医学部, 講師 (50304887)
NAGASAWA Kohei 佐賀大学, 佐賀大学, 教授 (00108721)
|
Project Period (FY) |
2010 – 2012
|
Project Status |
Completed (Fiscal Year 2012)
|
Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2012: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2011: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2010: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
Keywords | 腎臓学 / 全身性エリテマトーデス / ループス腎炎 / インターフェロン調節因子 / Toll-like レセプター / siRNA / Toll-likeレセプター / インターフェロン制御因子 |
Research Abstract |
Interferon regulatory factor 5 (IRF5) is a transcription factor and considered to be involved in the development of systemic lupus erythematosus. We generated IRF5-deficient lupus (MRL/lpr) mice and investigated their phenotype. Autoantibodies to nuclear antigens, including anti-nuclear antibodies and anti-dsDNA antibodies were lower or negative in the mouse sera. Lupus nephritis was much milder, and the mice survive much longer than control MRL/lpr mice. Splenic dendritic cells produced lower levels of inflammatory cytokines in response to To l l-like receptor ligands. These results show that IRF5 is a crucial driver of lupus nephritis and indicate that IRF5 may be an attractive new target for the treatment of lupus nephritis.
|
Report
(4 results)
Research Products
(27 results)